Ex vivo human placental transfer of anti-human immunodeficiency virus compounds

Infectious Diseases in Obstetrics and Gynecology

Volumn 5, Issue 4, 1997, Pages 310-315

  Bawdon, Roger E ^a,b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Diffusion; Nucleosides; Perfusion; Protease inhibitors

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ATEVIRDINE MESYLATE; DEOXYCYTIDINE; DIDANOSINE; DOUBLE STRANDED DNA; INDINAVIR; LAMIVUDINE; NELFINAVIR; NUCLEOSIDE; PHENAZONE; PROTEINASE; PROTEINASE INHIBITOR; RIBONUCLEASE; RITONAVIR; SAQUINAVIR; STAVUDINE; UNCLASSIFIED DRUG; VIROCEPT; VIRUS DNA; VIRUS RNA; ZALCITABINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DRUG CLEARANCE; DRUG DIFFUSION; DRUG RESISTANCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MUTATION; NONHUMAN; PLACENTAL TRANSFER; PRIORITY JOURNAL; REVIEW; TERATOGENICITY;

EID: 0031417002     PISSN: 10647449     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1098-0997(1997)5:4<310::aid-idog9>3.0.co;2-%23     Document Type: Review

References (30)

1. Centers for Disease Control and Prevention: First 500,000 AIDS cases - United States. JAMA 247:952-955, 1995.
2. Davis SF, Byers RH, Lindegran ML, et al.: Prevalence and incidence of vertically acquired HIV infection in the United States. JAMA 247:952-955, 1995.
3. Wilfert CM: Beginning to make progress against HIV. N Engl J Med 335:1678-1680, 1996.
4. Klug S, Lewandowski C, Merker HJ, Stahlmann R, Wildi L, Neubert D: In vitro and in vivo studies on the prenatal toxicity of five virustatic nucleoside analogues in comparison to acyclovir. Arch Toxicol 65:283-291, 1991.
5. Sieh E, Coluzzi ML, Cusella De Angelis MG, et al.: The effects of AZT and ddI on pre- and postimplantation mammalian embryos: An in vivo and in vitro study. AIDS Res Hum Retrovirus 8:639-649, 1992.
6. Gogu SR, Beckman BS, Agrawal KC: Amelioration of zidovudine-induced fetal toxicity in pregnant mice. Antimicrob Agents Chemother 362:370-374, 1992.
7. Toltzis P, Mourton T, Magnuson T: Effect of zidovudine on preimplantation murine embryos. Antimicrob Agents Chemother 37:1610-1613, 1993.
8. Christmas JT, Little BB, Knoll KA, Bawdon RE, Gilstrap LC: Teratogenic and embryocidal effect of zidovudine (AZT) in Sprague-Dawley rats. Infect Dis Obstet Gynecol 2:223-227, 1995.
9. American College of Obstetricians and Gynecologists: Educ Bull 232:1-8, 1997.
10. Challier JC: Criteria for evaluating perfusion experiments and presentation of results. Contrib Gynecol Obstet 13:32-39, 1985.
11. Schneider H, Huck A: Dual in vitro perfusion of an isolated lake of human placentas: Method and instrumentation. 13:40-17, 1985.
12. Fortunato SJ, Bawdon RE, Maberry MM, Swan KF: Transfer of ceftizoxime surpasses that of cefoperazone by the isolated human placenta perfused in vitro. Obstet Gynecol 75:830-833, 1990.
13. Levy J (ed): The Viruses: The Retroviridae. Vol 1. New York: Plenum Press, p 190, 1992.
14. Rawn JD: Biochemistry. Burlington, NC: Neil Patterson Publishing, p 621, 1989.
15. Wainberg MA, Gu Z, Gao Q, Arts E, et al.: Clinical correlates and molecular basis of HIV drug resistance (review). J Acquired Immune Deficiency Syndrome Suppl 1:S36-46, 1993.
16. Liebes L, Mendoza S, Wilson D, Dancis J: Transfer of zidovudine (AZT) by human placenta. J Infect Dis 161: 203-207, 1990.
17. Schenker S, Johnson RF, King TS, Schenken RS, Henderson GI: Azidothymidine (zidovudine) transport by the human placenta. Am J Med Sci 229:16-20, 1990.
18. Bawdon RE, Sobhi S, Dax J: The transfer of anti-human immunodeficiency virus nucleoside compounds by the term human placenta. Am J Obstet Gynecol 167:1570-1574, 1992.
19. Watts DH, Brown ZA, Tartaglione T, Burchett SD, et al.: Pharmacokinetic disposition of zidovudine during pregnancy. J Infect Dis 163:226-232, 1991.
20. Bawdon RE, Kaul S, Sobhi S: The ex vivo human placental transfer of the anti-HIV nucleoside compound d4T. Gynecol Obstet Invest 38:1-4, 1994.
21. Bloom SL, Dias KM, Bawdon RE, Gilstrap LC III: The maternal-fetal transfer of lamivudine in the ex vivo human placenta. Infect Dis Obstet Gynecol (in press).
22. Physicians' Desk Reference, 1997.
23. Moodly J, Moodly D, Pellay K, et al.: Antiviral effect of lamivudine along and in combination with zidovudine in HIV infected women. Abstract, 4th Conference on Retrovirus and Opportunistic Infections, 1997.
24. Benirschke K, Kaufmann P: Placental types. In Benirschke K, Kaufman P (eds): Pathology of the Human Placenta. 2nd ed. New York: Springer-Verlag, 1990.
25. Pereira CM, Nosbisch C, Winter HR, et al.: Transplacental pharmacokinetics of dideoxyinosine in pigtailed macaques. Antimicrob Agents Chemother 38:781-786, 1994.
26. Odinecs A, Nosbisch C, Keller RD, et al.: In vivo maternal-fetal pharmacokinetics of stavudine (2′,3′ didehydro-3′-deoxythymidine) in pigtailed macaques (Macaca nemestrina). Antimicrob Agents Chemother 40:196-202, 1996.
27. Deeks SG, Smith M, Halodniy M, Kahn JO: HIV protease inhibitors. A review for clinicians. JAMA 277:145-153, 1997.
28. Casey B, Bawdon R: Placental transfer of ritonavir with zidovudine in the ex vivo placental perfusion model. Abstract, Society for Gynecologic Investigation, 1997.
29. Roberts S, Bawdon RE, Sobhi S, Dax J, Gilstrap L III: The maternal-fetal transfer of bisheteroypiperazine (U-87201-E) in the ex vivo human placenta. Am J Obstet Gynecol 172:88-91, 1995.
30. Carpenter CCJ, Fischl MA, Hammer SM, et al.: Anti-retroviral therapy for HIV infections in 1997. Updated Recommendations of the International AIDS Society-USA Panel. JAMA 277:1962-1969, 1997.